Recent Finacing
Recent Raise
Caldera Pharmaceuticals and subsidiary XRpro provide label-free, high-throughput drug-discovery services—Molecular X‑Ray Fluorescence–based screens for real-time ion-channel kinetics and enzyme activity in intact cells (~10,000 compounds/day).
Recent Investors
Total Raised
Funding round
Investor